{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,20]],"date-time":"2025-03-20T12:40:26Z","timestamp":1742474426124,"version":"3.40.1"},"reference-count":13,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Anemia is frequent in palliative care, and transfusions are often used to correct it. Research indicates that transfusions are sometimes based solely on hemoglobin levels rather than patients' symptoms and administered in those with very short survival.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Objective:<\/jats:title>\n            <jats:p>To survey the transfusion practice of Portuguese palliative teams.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>This is a multicentric and retrospective study involving patients who received red blood cell transfusions in 2021, followed by palliative care teams.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>Five palliative care teams participated and included 86 patients who underwent 122 transfusion episodes; 49 (57%) were male, and the median age was 76 years (43\u2013100). The median hemoglobin level before transfusion was 7.4 g\/dL (3.7\u201311.5). Symptomatic improvement was observed in 30 (25%) episodes; in 19 (16%), there was no improvement; and the outcome was not recorded in 73 (60%). Fatigue (38%) and low hemoglobin level (37%) were the most common reasons for transfusion. Decisions to transfuse, recorded primarily by one palliative care team, were often made by nonpalliative care doctors concurrently treating these patients, mostly in the emergency department. Those patients had more complications and significantly shorter survival compared with those whose transfusions were decided by palliative care physicians.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>The decisions made by palliative care physicians regarding red blood cell transfusion deviated from the recommendations as seen in other similar studies.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/j.pbj.0000000000000285","type":"journal-article","created":{"date-parts":[[2025,3,20]],"date-time":"2025-03-20T12:22:31Z","timestamp":1742473351000},"update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Red cell transfusions in patients with cancer in palliative care: a multicentric study"],"prefix":"10.1097","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9506-7106","authenticated-orcid":false,"given":"Jos\u00e9 Ant\u00f3nio","family":"Ferraz-Gon\u00e7alves","sequence":"first","affiliation":[{"name":"Faculty of Medicine, University of Porto, Porto, Portugal"}]},{"given":"Florbela","family":"Gon\u00e7alves","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, University of Porto, Porto, Portugal"},{"name":"Portuguese Institute of Oncology Francisco Gentil Coimbra, Coimbra, Portugal"}]},{"given":"Jorge","family":"de Castro","sequence":"additional","affiliation":[{"name":"Internal Medicine Department, Champalimaud Foundation, Lisbon, Portugal"}]},{"given":"Margarida","family":"Gaud\u00eancio","sequence":"additional","affiliation":[{"name":"Portuguese Institute of Oncology Francisco Gentil Coimbra, Coimbra, Portugal"}]},{"given":"Micaela","family":"Sousa","sequence":"additional","affiliation":[{"name":"Internal Medicine Department, Northeast Local Health Unit, Macedo de Cavaleiros, Portugal"}]},{"given":"Rafael","family":"Mu\u00f1oz-Romero","sequence":"additional","affiliation":[{"name":"Unidade Local de Sa\u00fade do Algarve, E.P.E., Unidade Hospitalar de Faro, Faro, Portugal"}]},{"given":"Susete","family":"Freitas","sequence":"additional","affiliation":[{"name":"Palliative Care Unit\u2014SESARAM, E.P.E., Funchal, Portugal"}]}],"member":"276","published-online":{"date-parts":[[2025,3]]},"reference":[{"issue":"suppl 7A","key":"R1-20250320","doi-asserted-by":"crossref","first-page":"11S","DOI":"10.1016\/j.amjmed.2003.12.008","article-title":"Prevalence and outcomes of anemia in cancer: a systematic review of the literature","volume":"116","author":"Knight","year":"2004","journal-title":"Am J Med"},{"issue":"2","key":"R2-20250320","doi-asserted-by":"crossref","first-page":"482","DOI":"10.3390\/nu13020482","article-title":"Cancer related anemia: an integrated multitarget approach and lifestyle interventions","volume":"13","author":"Natalucci","year":"2021","journal-title":"Nutrients"},{"issue":"8","key":"R3-20250320","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1182\/bloodadvances.2018030387","article-title":"Management of cancer-associated anemia with erythropoiesis-stimulating agents: ASCO\/ASH clinical practice guideline update","volume":"3","author":"Bohlius","year":"2019","journal-title":"Blood Adv"},{"issue":"1","key":"R4-20250320","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1177\/0269216318801755","article-title":"National comparative audit of red blood cell transfusion practice in hospices: recommendations for palliative care practice","volume":"33","author":"Neoh","year":"2019","journal-title":"Palliat Med"},{"issue":"3","key":"R5-20250320","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1177\/1049909118806456","article-title":"A retrospective chart review of transfusion practices in the palliative care unit setting","volume":"36","author":"Sirianni","year":"2019","journal-title":"Am J Hosp Palliat Care"},{"issue":"13","key":"R6-20250320","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1056\/NEJMra1612789","article-title":"Indications for and adverse effects of red-cell transfusion","volume":"377","author":"Carson","year":"2017","journal-title":"N Engl J Med"},{"key":"R7-20250320","doi-asserted-by":"crossref","first-page":"17","DOI":"10.2147\/IJCTM.S77343","article-title":"Transfusion-associated circulatory overload (TACO): prevention, management, and patient outcomes","volume":"3","author":"Murphy","year":"2015","journal-title":"Int J Clin Transfus Med"},{"key":"R8-20250320","doi-asserted-by":"crossref","first-page":"h5832","DOI":"10.1136\/bmj.h5832","article-title":"Blood transfusion: summary of NICE guidance","volume":"351","author":"Padhi","year":"2015","journal-title":"BMJ"},{"issue":"19","key":"R9-20250320","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1001\/jama.2023.12914","article-title":"Red blood cell transfusion: 2023 AABB international guidelines","volume":"330","author":"Carson","year":"2023","journal-title":"JAMA"},{"issue":"6","key":"R10-20250320","doi-asserted-by":"crossref","first-page":"e195","DOI":"10.1097\/j.pbj.0000000000000195","article-title":"Transfusion practices in patients with advanced cancer: a retrospective study in a palliative care service","volume":"7","author":"Marote","year":"2022","journal-title":"Porto Biomed J"},{"issue":"6","key":"R11-20250320","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1177\/0269216308094104","article-title":"Validation of a consciousness level scale for palliative care","volume":"22","author":"Gon\u00e7alves","year":"2008","journal-title":"Palliat Med"},{"issue":"5","key":"R12-20250320","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1177\/02692163221081967","article-title":"Practice review: evidence-based and effective management of anaemia in palliative care patients","volume":"36","author":"Neoh","year":"2022","journal-title":"Palliat Med"},{"issue":"1","key":"R13-20250320","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/tme.12481","article-title":"The administration of blood components: a British Society for Haematology Guideline","volume":"28","author":"Robinson","year":"2018","journal-title":"Transfus Med"}],"container-title":["Porto Biomedical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/j.pbj.0000000000000285","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,20]],"date-time":"2025-03-20T12:22:43Z","timestamp":1742473363000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/j.pbj.0000000000000285"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":13,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/j.pbj.0000000000000285","relation":{},"ISSN":["2444-8672"],"issn-type":[{"value":"2444-8672","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"2025-02-03","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-02-18","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}